| Model Number |
WCD 4000 |
| Health Effect - Clinical Code |
Shock from Patient Lead(s) (3162)
|
| Date of Event |
07/28/2021
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
The monitor sn (b)(4) and electrode belt sn (b)(4) have not been returned for evaluation.Based on the data available at this time, there is no indication of a device malfunction causing or contributing to the inappropriate treatment.Inappropriate defibrillations are an anticipated risk associated with the use of the hospital wearable defibrillator.Patients are instructed through alarms, voice messages, ifu, and training to press the response buttons to prevent an inappropriate defibrillation.The current commercial inappropriate defibrillation rate is consistent with the observed rate during the pivotal clinical trial (b)(4) (0.69% per patient-month with 90% confidence).A summary of the safety and effectiveness data (ssed), including the inappropriate defibrillation safety objective supporting fda's approval of the lifevest and hwd, can be found at (http://www.Accessdata.Fda.Gov/cdrh_docs/pdf/p010030b.Pdf).The zoll detection algorithm complies with iec 60601-2-4 performance requirements for sensitivity and specificity.
|
| |
|
Event or Problem Description
|
|
The patient was inappropriately treated three times.The patient's neurological status at the time of the event is unknown.Interference and artifact contributed to the false detection.The response buttons were not pressed during the event.No injury was reported from the treatment.No deficiencies were alleged against the device.
|
| |
|
Event or Problem Description
|
|
Supplemental report 9/9/2021: this report was submitted in error.The treatment events occurred as part of a demonstration of the device and not while the device was being worn by a patient.The patient was inappropriately treated three times.The patient's neurological status at the time of the event is unknown.Interference and artifact contributed to the false detection.The response buttons were not pressed during the event.No injury was reported from the treatment.No deficiencies were alleged against the device.
|
| |
|
Additional Manufacturer Narrative
|
|
The monitor sn (b)(6) and electrode belt sn (b)(6) have not been returned for evaluation.Based on the data available at this time, there is no indication of a device malfunction causing or contributing to the inappropriate treatment.Inappropriate defibrillations are an anticipated risk associated with the use of the hospital wearable defibrillator.Patients are instructed through alarms, voice messages, ifu, and training to press the response buttons to prevent an inappropriate defibrillation.The current commercial inappropriate defibrillation rate is consistent with the observed rate during the pivotal clinical trial (b)(4) (0.69% per patient-month with 90% confidence).A summary of the safety and effectiveness data (ssed), including the inappropriate defibrillation safety objective supporting fda's approval of the lifevest and hwd, can be found at (http://www.Accessdata.Fda.Gov/cdrh_docs/pdf/p010030b.Pdf).The zoll detection algorithm complies with iec 60601-2-4 performance requirements for sensitivity and specificity.
|
| |
|
Search Alerts/Recalls
|